Suchergebnisse - "Lederer, David J"

PubPharm (310)

41

Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease : a double-blind, randomised, placebo-controlled, phase 2 trial

enthalten in: The Lancet. Respiratory medicine | 2020

von Maher, T. | Corte, T. | Fischer, A. | +8

CommentIn: Lancet Respir Med. 2020 Feb;8(2):126-127. - PMID 31578170

42

Genome-wide association study of susceptibility to idiopathic pulmonary fibrosis

enthalten in: bioRxiv.org | 2020

von Allen, R. | Guillen-Guio, B. | Oldham, J. | +57

43

Risk factors for disease progression in idiopathic pulmonary fibrosis

enthalten in: Thorax | 2020

von Raghu, G. | Ley, B. | Brown, K. | +18

44

Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease : a double-blind, randomised, placebo-controlled, phase 2 trial

enthalten in: The lancet / Respiratory medicine | [February 2020]

von Maher, T. | Corte, T. | Fischer, A. | +8

45

Development and reporting of prediction models : Guidance for authors from editors of respiratory, sleep, and critical care journals

enthalten in: Critical care medicine | 2020

von Leisman, D. | Harhay, M. | Lederer, D. | +36

46

Diagnosis of hypersensitivity pneumonitis in adults : an official ATS/JRS/ALAT clinical practice guideline

enthalten in: American journal of respiratory and critical care medicine | August 1, 2020

von Raghu, G. | Remy-Jardin, M. | Ryerson, C. | +39

47

Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE) : a phase 2, randomised, double-blind, placebo-controlled trial

enthalten in: The Lancet. Respiratory medicine | 2020

von Richeldi, L. | Fernández Pérez, E. | Costabel, U. | +14

CommentIn: Lancet Respir Med. 2020 Jan;8(1):2-3. - PMID 31575507

48

Regional distribution of high-attenuation areas on chest computed tomography in the Multi-Ethnic Study of Atherosclerosis

enthalten in: ERJ open research | 2020

von Choi, B. | Kawut, S. | Raghu, G. | +7

49

Reference values for high attenuation areas on chest CT in a healthy, never‐smoker, multi‐ethnic sample : The MESA study

enthalten in: Respirology | 2020

von Easthausen, I. | Podolanczuk, A. | Hoffman, E. | +9

50

Concomitant medications and clinical outcomes in idiopathic pulmonary fibrosis

enthalten in: The European respiratory journal | 2019

von Kreuter, M. | Lederer, D. | Cottin, V. | +7